Evidence map›Paper›PMID 35698475›Full record

ArticleJournal of experimental pharmacology2022

Hypoglycemic, Antihyperglycemic, and Toxic Effects of

Félicien Mushagalusa Kasali, Justin Ntokamunda Kadima, Jonans Tusiimire, Amon Ganafa Agaba

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Félicien Mushagalusa KasaliPharm-Bio Technology and Traditional Medicine Center, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0001-5956-2110
Justin Ntokamunda KadimaDepartment of Pharmacy, Official University of Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0000-0003-0395-7935
Jonans TusiimireDepartment of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0002-5831-1499
Amon Ganafa AgabaDepartment of Pharmacology and Therapeutics, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0003-1411-6517
Mbarara University of Science and Technology · UGUniversité Officielle de Bukavu · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We prepared various doses (100, 200, 400 mg/kg) of aqueous and methanolic leaf extracts for the antidiabetic study, and a dose of 2000 mg/Kg was prepared for the acute toxicity test. The first group that evaluated the hypoglycemic effect consisted of forty normoglycemic Wistar rats aged 7-8 months old with a weighted average of 265.8 ± 24.6 g. The second group consisted of intraperitoneal glucose-loaded male animals to evaluate the antihyperglycemic effect. The third group contained two groups of normoglycemic female rats (n = 3), aged 3 and 4 months old (weight average: 187.45 ± 14.82 g), treated for 14 days with aqueous and methanolic extracts (2 g/kg b.w) to assess mortality and toxic effects. Blood samples were taken at 30, 60, 90, and 120 min post-treatment in hypoglycemic and antihyperglycemic evaluations. Glibenclamide (5 mg/kg) was used as a reference drug. The control animals in each group did not receive the extracts. Results: In hypoglycemic rats, 100 mg/kg of aqueous and methanolic extracts significantly lowered the fasting blood glucose level by 13.92% ( Conclusion: Crude aqueous and methanolic leaf extracts of

Indexed as

antidiabetic bioactivityleaf extractsPhysalis peruvianaratstoxicity

Identifiers

PMID35698475
PMCPMC9188478
OpenAlexW4282034470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.